Skip to content
MedGenome US is now rebranded as Signios Bio – same team, renewed identity.
  • Login
  • Contact
Signiosbio powered by medgenome
  • Sequencing Services
    • Single Cell Sequencing
    • Spatial Transcriptomics
    • RNA Sequencing
    • Immune Profiling
    • Proteomics
    • Long Read Sequencing
    • Premade Library Sequencing
    • Whole Genome Sequencing
    • Whole Exome Sequencing
    • Oncology Panel Sequencing
    • Epigenomics
    • Certified Service Provider
  • Multiomics Solutions
    • Academics and Research Institutes
    • Pharmaceutical and Biotechnology Companies
    • Clinical and Diagnostics Laboratories
    • Contract Research Organizations
  • Bioinformatics Solutions
  • Resources
    • Documents
    • Publications
    • Blog
    • Posters & Videos
    • FAQs
  • Company
    • About
    • News & Events
    • Grants
    • Careers
    • Contact
Signiosbio powered by medgenome
  • Sequencing Services
    • Single Cell Sequencing
    • Spatial Transcriptomics
    • RNA Sequencing
    • Immune Profiling
    • Proteomics
    • Long Read Sequencing
    • Premade Library Sequencing
    • Whole Genome Sequencing
    • Whole Exome Sequencing
    • Oncology Panel Sequencing
    • Epigenomics
    • Certified Service Provider
  • Multiomics Solutions
    • Multiomics – Academics and Research Institutes
    • Multiomics – Pharmaceutical & Biotechnology Companies
    • Multiomics – Clinical & Diagnostics Laboratories
    • Multiomics – Contract Research Organizations
  • Bioinformatics Solutions
  • Resources
    • Documents
    • Publications
    • Blog
    • Posters & Videos
  • Company
    • About
    • News & Events
    • Careers
    • Contact
  • Login

2021

Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibility

April 12, 2021

Whole-exome sequencing identifies two novel ALMS1 mutations in Indian patients with Leber congenital amaurosis

March 29, 2021

The Spectrum of Clinical, Immunological, and Molecular Findings in Familial Hemophagocytic Lymphohistiocytosis: Experience From India

March 25, 2021

A Young Girl With Bronchiectasis and Elevated Sweat Chloride

March 25, 2021

Clinical Study of 668 Indian Subjects with Juvenile, Young, and Early Onset Parkinson’s Disease

March 9, 2021

The Spectrum of Clinical, Immunological, and Molecular Findings in Familial Hemophagocytic Lymphohistiocytosis: Experience From India

March 5, 2021

Novel CTSF Indel in a patient with Kufs disease and resistant schizophrenia: A case report

February 9, 2021

BCR-ABL1 kinase domain mutation analysis by next generation sequencing detected additional mutations in chronic myeloid leukemia patients with suboptimal response to imatinib

January 22, 2021

Genetic Testing in Neonatal Intensive Care: Experience from a Tertiary Care Unit

January 6, 2021
Post pagination
← Previous 1 2 3
Locations:
US:

Signios Biosciences
348 Hatch Drive Foster City, CA 94404, USA
Call us: +1 888-440-0954
Email us: info@signiosbio.com

Registered Office:
MedGenome Inc. 108 West 13th Street Wilmington, Delaware 19801, County of New Castle, USA

India:
MedGenome Labs Ltd.
Sy. Nos. 94/1C and 94/2, Tower 1, Ground Floor, Veerasandra Village, Attibele Hobli, Electronic City Phase-1, Electronics City, Bangalore, Bangalore South, Karnataka, India, 560100
  • Sequencing Services
  • Multiomics Solutions
  • Bioinformatics Solutions
  • Resources
  • Company
  • Login
  • Contact

Stay ahead with exclusive insights, tips, and trends tailored for the multiomics and bioinformatics fields. Subscribe to our newsletter.

 

© 2026 SIGNIOSBIO. All Rights Reserved.